Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CryoPort (CYRX) Stock Price & Analysis
557 Followers
CYRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.32 - $20.11
Previous Close$8.81
Volume557.74K
Average Volume (3M)782.37K
Market Cap
$433.96M
Enterprise Value$400.35M
Total Cash (Recent Filing)$448.54M
Total Debt (Recent Filing)$414.94M
Price to Earnings (P/E)―
Beta2.61
Next Earnings
Aug 06, 2024EPS Estimate
-$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.47
Shares Outstanding49,257,444
10 Day Avg. Volume690,825
30 Day Avg. Volume782,373
Standard Deviation0.21
R-Squared0.17
Alpha-0.00829
Financial Highlights & Ratios
Price to Book (P/B)2.99
Price to Sales (P/S)2.05
Price to Cash Flow (P/CF)48.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.78
Enterprise Value/Gross Profit4.03
Enterprise Value/Ebitda-5.25
Forecast
1Y Price Target
$18.00Price Target Upside104.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
CryoPort News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTop line grew 5%, primarily driven by growing Biopharma revenue and the Reproductive Medicine Business.
Market RecoveryThe bio-pharma industry has started to see signs of improvement including more clinical trial activity, new drug approvals, and funding flowing into the space.
Revenue GuidanceCYRX re-affirmed full-year 2024E revenue guidance of $242M-$252M, and CYRX expects to ramp revenue through the year as demand improves and the market recovers.
Bears Say
EarningsBoth top line and bottom line were lower than consensus estimates, with revenue in line with previously announced FY23 guidance.
Market EnvironmentCYRX continues to face a challenging demand environment and pressure on MVE.
RevenueCYRX missed expectations in 1Q24, reporting revenue of $54.6M versus consensus of $58.8M.
---
Ownership Overview
3.38% Insiders
33.98% Mutual Funds
21.81% Other Institutional Investors
40.82% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $5.32 and its highest was $20.11 in the past 12 months.
What is CryoPort Inc’s market cap?
Currently, no data Available
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Aug 06, 2024 which is in 9 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on May 07, 2024. The company reported -$0.43 earnings per share for the quarter, missing the consensus estimate of -$0.345 by -$0.085.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -$0.39.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 49,257,442 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.43 in its last earnings report, missing expectations of -$0.345. Following the earnings report the stock price went down -19.512%.
Which hedge fund is a major shareholder of CryoPort Inc?
Among the largest hedge funds holding CryoPort Inc’s share is Blackstone Inc.. It holds CryoPort Inc’s shares valued at 8M.
---
CryoPort Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.00 (104.31% Upside)
$18.00 (104.31% Upside)
Blogger Sentiment
Neutral
CYRX Sentiment 50%
Sector Average 67%
Sector Average 67%
Insider Transactions
Sold Shares
Worth $154.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-46.08%
12-Months-Change
Fundamentals
Return on Equity
-21.87%
Trailing 12-Months
Asset Growth
-10.04%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
---
CYRX Earnings Call
Q1 2024
0:00 / 0:00
---
CYRX Stock 12 Month Forecast
Average Price Target
$18.00
▲(104.31% Upside)
Technical Analysis
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
1/21 ratings generated profit
1 Year Average Return
-37.82%
reiterated a buy rating 3 months ago
Copying David Saxon's trades and holding each position for 1 Year would result in 4.76% of your transactions generating a profit, with an average return of -37.82% per trade.
---